NCT01420250 2025-05-15
Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer
Thomas Jefferson University
Phase 1 Completed
Thomas Jefferson University
University of California, San Francisco
Merrimack Pharmaceuticals
Sanofi
Icahn School of Medicine at Mount Sinai
Sanofi
Sanofi
Sanofi